AlphaGenome 2 pinpoints cell specific disease drivers
According to Google DeepMind on X, AlphaGenome 2 is a new AI model that analyzes cell specific effects of single letter DNA changes to help scientists study disease.
SourceAnalysis
Google DeepMind announced AlphaGenome 2 on November 11, 2026, a new AI model that examines cell-specific effects of single-letter DNA changes to clarify disease mechanisms in tissues such as the heart, brain, and immune system.
According to Google DeepMind, the model helps scientists identify drivers of disease by focusing on individual cell types that share identical DNA sequences. This development boosts researcher productivity by automating the interpretation of genetic variants in targeted cellular contexts, reshaping workflows from broad genomic scans to precise, cell-level analysis. It carries concrete implications for the broader AI ecosystem by advancing specialized models that integrate genomics with cell biology, opening pathways for more accurate disease modeling tools across the life sciences sector.
Google DeepMind
@GoogleDeepMindWe’re a team of scientists, engineers, ethicists and more, committed to solving intelligence, to advance science and benefit humanity.